Biotechnology (525) | Lease Agreements (525)

Browse by Company

89bio, Inc. (1)
ACADIA PHARMACEUTICALS INC (2)
Achaogen, Inc. (1)
ACHIEVE LIFE SCIENCES, INC. (1)
ADURO BIOTECH, INC. (1)
Advaxis, Inc. (2)
Adverum Biotechnologies, Inc. (1)
Aeglea BioTherapeutics, Inc. (1)
AGENUS INC (1)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (3)
AILERON THERAPEUTICS INC (1)
Aimmune Therapeutics, Inc. (2)
AKCEA THERAPEUTICS, INC. (1)
Akebia Therapeutics, Inc. (2)
Akero Therapeutics, Inc. (1)
ALBIREO PHARMA, INC. (2)
Aldeyra Therapeutics, Inc. (1)
Alector, Inc. (2)
Alkermes plc. (3)
Allakos Inc. (1)
Alliqua BioMedical, Inc. (1)
Allogene Therapeutics, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (1)
ALPINE IMMUNE SCIENCES, INC. (1)
AMARIN CORP PLC (2)
AMICUS THERAPEUTICS, INC. (1)
AmpliPhi Biosciences Corp (1)
ANAPTYSBIO INC (2)
Apellis Pharmaceuticals, Inc. (4)
Applied Molecular Transport Inc. (2)
Aptevo Therapeutics Inc. (2)
AQUINOX PHARMACEUTICALS, INC (5)
Aravive, Inc. (1)
ARCA biopharma, Inc. (3)
Arcturus Therapeutics Holdings Inc. (3)
Arcus Biosciences, Inc. (2)
Arcutis Biotherapeutics, Inc. (2)
ARDELYX, INC. (1)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (7)
Arsanis, Inc. (4)
ARYA Sciences Acquisition Corp II (2)
Atara Biotherapeutics, Inc. (1)
Atreca, Inc. (5)
Aurinia Pharmaceuticals Inc. (3)
AVEO PHARMACEUTICALS INC (1)
Avidity Biosciences, Inc. (4)
Axcella Health Inc. (3)
Ayala Pharmaceuticals, Inc. (1)
Beam Therapeutics Inc. (2)
BICYCLE THERAPEUTICS Ltd (1)
BIO-PATH HOLDINGS INC (1)
BIOCEPT INC (2)
Biomea Fusion, Inc. (1)
BIOSPECIFICS TECHNOLOGIES CORP (2)
BIOTIME INC (1)
BioXcel Therapeutics, Inc. (1)
Black Diamond Therapeutics, Inc. (2)
bluebird bio, Inc. (2)
Blueprint Medicines Corp (1)
BridgeBio Pharma, Inc. (1)
Cabaletta Bio, Inc. (1)
Calithera Biosciences, Inc. (1)
CareDx, Inc. (1)
CASI Pharmaceuticals, Inc. (1)
CASTLE BIOSCIENCES INC (8)
CATABASIS PHARMACEUTICALS INC (1)
CATALYST BIOSCIENCES, INC. (1)
CATALYST PHARMACEUTICALS, INC. (1)
Celcuity Inc. (1)
Celldex Therapeutics, Inc. (3)
Cellular Biomedicine Group, Inc. (3)
Celsion CORP (1)
Chanticleer Holdings, Inc. (1)
Chardan Healthcare Acquisition Corp. (2)
ChemoCentryx, Inc. (2)
CHIMERIX INC (2)
Constellation Alpha Capital Corp. (5)
CONSTELLATION PHARMACEUTICALS INC (2)
Corbus Pharmaceuticals Holdings, Inc. (2)
Corvus Pharmaceuticals, Inc. (1)
CRISPR Therapeutics AG (3)
CURIS INC (1)
Cyclerion Therapeutics, Inc. (3)
Cytokinetics, Incorporated (3)
CYTRX CORP (2)
Deciphera Pharmaceuticals, Inc. (3)
Dicerna Pharmaceuticals Inc (2)
DYADIC INTERNATIONAL INC (2)
DYNAVAX TECHNOLOGIES CORP (2)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (1)
Eidos Therapeutics, Inc. (1)
EXACT SCIENCES CORP (8)
Exelixis (6)
EXICURE, INC. (1)
FATE THERAPEUTICS INC (1)
FIVE PRIME THERAPEUTICS INC (1)
Flexion Therapeutics Inc (1)
Frequency Therapeutics, Inc. (4)
Gemphire Therapeutics Inc. (4)
Generation Bio Co. (2)
GENOCEA BIOSCIENCES, INC. (2)
GeoVax Labs, Inc. (1)
GERON CORP (4)
Gritstone Oncology, Inc. (4)
GTX INC (2)
HEAT BIOLOGICS, INC. (1)
HERON THERAPEUTICS, INC. (1)
HISTOGENICS CORP (4)
HOOKIPA Pharma Inc. (2)
IDEAYA Biosciences, Inc. (4)
IDERA PHARMACEUTICALS, INC. (1)
IGM Biosciences, Inc. (1)
IMMUNOGEN INC (1)
IMMUNOMEDICS INC (1)
INFINITY PHARMACEUTICALS, INC. (1)
InMed Pharmaceuticals Inc. (1)
INSMED Inc (2)
Intellia Therapeutics, Inc. (3)
INTERCEPT PHARMACEUTICALS, INC. (1)
International Stem Cell CORP (1)
Invitae Corp (1)
IOVANCE BIOTHERAPEUTICS, INC. (6)
IRONWOOD PHARMACEUTICALS INC (3)
Isoray, Inc. (1)
KalVista Pharmaceuticals, Inc. (1)
Karuna Therapeutics, Inc. (2)
Karyopharm Therapeutics Inc. (1)
Keros Therapeutics, Inc. (1)
Kezar Life Sciences, Inc. (1)
Kindred Biosciences, Inc. (1)
Kiniksa Pharmaceuticals, Ltd. (1)
Kodiak Sciences Inc. (1)
Krystal Biotech, Inc. (11)
Kura Oncology, Inc. (7)
LEXICON PHARMACEUTICALS, INC. (1)
LifeSci Acquisition Corp. (1)
LogicBio Therapeutics, Inc. (1)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (2)
MeiraGTx Holdings plc (4)
Mersana Therapeutics, Inc. (2)
Millendo Therapeutics, Inc. (4)
MiMedx Group, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (2)
Mirati Therapeutics, Inc. (5)
Mirum Pharmaceuticals, Inc. (2)
Moderna, Inc. (1)
Molecular Templates, Inc. (2)
Momenta Pharmaceuticals, Inc. (2)
Myriad Genetics, Inc. (1)
NantKwest, Inc. (5)
NEUROCRINE BIOSCIENCES INC (1)
Neurotrope, Inc. (1)
NextCure, Inc. (3)
NORTHWEST BIOTHERAPEUTICS INC (1)
NOVAVAX INC (3)
NTN BUZZTIME INC (1)
Ohr Pharmaceutical Inc (9)
OncoCyte Corp (2)
ONCOSEC MEDICAL Inc (2)
ORAGENICS INC (1)
Organogenesis Holdings Inc. (3)
ORGANOVO HOLDINGS, INC. (5)
Oric Pharmaceuticals, Inc. (1)
Outlook Therapeutics, Inc. (1)
Passage BIO, Inc. (4)
PDL BIOPHARMA, INC. (2)
Phio Pharmaceuticals Corp. (1)
PIERIS PHARMACEUTICALS, INC. (3)
POLARITYTE, INC. (3)
PORTOLA PHARMACEUTICALS INC (1)
PRECISION BIOSCIENCES INC (8)
Prevail Therapeutics Inc. (1)
Protagonist Therapeutics, Inc (1)
PROTEON THERAPEUTICS INC (1)
PTC THERAPEUTICS, INC. (3)
Radius Health, Inc. (1)
RAPT Therapeutics, Inc. (4)
Regeneron Pharmaceuticals (1)
REGENXBIO Inc. (7)
Regulus Therapeutics Inc. (6)
Replimune Group, Inc. (1)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (8)
REXAHN PHARMACEUTICALS, INC. (4)
RHYTHM PHARMACEUTICALS, INC. (1)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (1)
SANGAMO THERAPEUTICS, INC (6)
Savara Inc (1)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (2)
SELECTA BIOSCIENCES INC (1)
SELLAS Life Sciences Group, Inc. (1)
Seres Therapeutics, Inc. (1)
Sierra Oncology, Inc. (2)
SOLENO THERAPEUTICS INC (1)
Sorrento Therapeutics, Inc. (2)
Spectrum Pharmaceuticals, Inc. (2)
Spero Therapeutics, Inc. (1)
Spring Bank Pharmaceuticals, Inc. (1)
Stellar Biotechnologies, Inc. (1)
Stoke Therapeutics, Inc. (2)
Summit Therapeutics Inc. (1)
Surface Oncology, Inc. (1)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (3)
TCR2 THERAPEUTICS INC. (1)
Tocagen Inc (2)
Tonix Pharmaceuticals Holding Corp. (1)
Turning Point Therapeutics, Inc. (5)
Twist Bioscience Corp (4)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (10)
uniQure N.V. (1)
UroGen Pharma Ltd. (1)
Vanda Pharmaceuticals Inc. (2)
Vaxart, Inc. (2)
Vaxcyte, Inc. (4)
VBI Vaccines Inc (6)
Vericel Corp (1)
VICAL INC (1)
Viela Bio, Inc. (1)
Vir Biotechnology, Inc. (2)
VITAL THERAPIES INC (1)
Voyager Therapeutics, Inc. (1)
Xencor Inc (3)
Xenon Pharmaceuticals Inc. (1)
XOMA Corp (2)
ZAFGEN, INC. (2)
Zai Lab Ltd (1)
Zentalis Pharmaceuticals, LLC (9)
ZIOPHARM ONCOLOGY INC (5)

Recent Contracts

Sublease Agreement by and between Aravive, Inc. and Grail, Inc (Aravive, Inc., Filed With SEC on June 14, 2021)
Office Lease, dated June 3, 2021, between the Registrant and Overlook at Rob Roy Owner, LLC (Savara Inc, Filed With SEC on June 4, 2021)
Lease Modification, dated May 27, 2021, between Energy Northwest and Isoray Medical, Inc (Isoray, Inc., Filed With SEC on June 3, 2021)
Fifth Amendment to Lease, dated May 25, 2021, by and between Ardelyx, Inc. and 34175 Ardenwood Venture, LLC (ARDELYX, INC., Filed With SEC on June 1, 2021)
Lease, effective March 24, 2021, between Zentalis Pharmaceuticals, Inc. and ESRT 1359 Broadway, L.L.C (Zentalis Pharmaceuticals, LLC, Filed With SEC on May 17, 2021)
Fourth Amendment to Lease, dated May 4, 2021, to Lease Agreement between Precision BioSciences, Inc. and Durham TW Alexander, LLC, dated October 2, 2018, as amended (PRECISION BIOSCIENCES INC, Filed With SEC on May 13, 2021)
First Amendment to Lease Agreement dated May 12, 2021 by and between Turning Point Therapeutics, Inc. and ARE-SD Region No. 44, LLC (Turning Point Therapeutics, Inc., Filed With SEC on May 13, 2021)
Lease Agreement, dated as of March 23, 2021, by and between ARE-Maryland No. 31, LLC and the Registrant (TCR2 THERAPEUTICS INC., Filed With SEC on May 13, 2021)
Second Amendment to Lease, dated March 24, 2021, by and between Neoleukin Therapeutics, Inc. and ARE-Seattle No. 28, LLC (AQUINOX PHARMACEUTICALS, INC, Filed With SEC on May 12, 2021)
Sublease Agreement, dated March 26, 2021, by and among the Company, Vittoria Industries North America, Inc. and Waterfront Equity Partners, LLC (AILERON THERAPEUTICS INC, Filed With SEC on May 11, 2021)